Get the latest MDCO - The Medicines Company stock market performance data and financial news.
Get the latest MDCO - The Medicines Company together with stock market performance data and financial news.
Get the latest MDCO - The Medicines Company stock market performance data and financial news.
Read Jim Cramer's take on The Medicines Company (MDCO) and get his latest thoughts on the company?s performance and outlook
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
The Medicines Company announced announced it was ending a phase III trial of its new anti-clotting drug, nearly halving shares in pre-market trading.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10500386/1/medicines-abandons-drug-trials-shares-tank-45.html
The minimum price tag of the deal is $42 million.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10457496/1/medicines-co-to-acquire-targanta.html
Regulatory setbacks helped push Medicines Co. and other biotech stocks down.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10353503/1/fridays-health-winners-losers.html
The company made an upfront payment of $22.8 million for Curacyte Discovery GmbH, and could pay a milestone if the drug reaches phase II development.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/newsanalysis/transportation/10431999.html
The company slashes forecasts.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10245917/1/bitter-pill-for-medicines-co.html
Connect with TheStreet